ENTA

ENTA R&D Expense Growth

-18.81%Fiscal year

Period ending:

ENTA FY R&D Growth (YoY)%
ENTA FY R&D Growth (YoY)85.77%-30.89%
2010-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

ENTA r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 16 observations from Sep 30, 2010 to Sep 30, 2025.

Enanta Pharmaceuticals Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-18.8141%
-19.5983%
-0.6066%
-5.5074%
27.3151%
-3.8372%
49.9251%
65.1077%
41.9911%
74.4836%
23.7407%
11.2761%
11.4191%
30.8998%
18.8452%
0%

Compare r&d expense growth

All ENTA financial metrics · ENTA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.